CuraPep is a science-driven biotechnology company focused on developing practical, innovative solutions for wound care and skin health. The company’s mission is to address real-world challenges in wound and skin diseases through research, biotechnology, and product development, with an emphasis on patient care, scientific integrity, innovation, and accessible solutions.

CuraPep develops advanced wound-care products designed around modern principles of moisture balance and oxygen support. Its product portfolio includes Vitynex™ Cream, a topical wound-care product designed to support the skin’s healing environment, and VityPatch™ Hydrogel, an oxygen-permissive, moisture-balancing dressing designed for advanced wound care. The company also maintains a research and development pipeline focused on areas such as chronic wounds and diabetic ulcers.

CuraPep’s approach recognizes the importance of oxygen in tissue repair and incorporates oxygen-supportive concepts into its wound-care technology. This is distinct from oxygen therapy wound care, such as hyperbaric oxygen therapy, which involves delivering high-concentration oxygen in a pressurized chamber. CuraPep instead focuses on products designed to support the local wound environment without requiring specialized equipment.

For everyday topical care, Vitynex™ Cream is positioned as a wound care cream for supporting minor cuts, scrapes, skin tears, and burns, while certain more complex wounds require guidance from a healthcare professional. CuraPep provides its products and educational resources to help patients, healthcare professionals, researchers, and partners better understand modern approaches to wound healing and skin recovery.

CuraPep is based at 9169 W State St #933, Garden City, ID 83714, USA, and welcomes collaboration with healthcare professionals, researchers, partners, and others interested in advancing wound-care innovation.